Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine versus placebo, cetirizine, and fexofenadine in seasonal allergic rhinitis in the Vienna Challenge Chamber
2006-003004-19Phase 3Completed
- Sponsor
- Faes Farma
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bilastine in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Faes Farma. Primary endpoints: Weighted mean total nasal symptom score, Clinical efficacy of bilastine versus placebo and 1 more. Started Sep 2006; status: completed.
02
Drugs
bilastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2006-003004-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003004-19.